UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

GNG5 is an unfavourable independent prognostic indicator of gliomas

Journal of cellular and molecular medicine, 2020-11, Vol.24 (21), p.12873-12878

2020

Volltextzugriff (PDF)

Silencing SATB1 overcomes temozolomide resistance by downregulating MGMT expression and upregulating SLC22A18 expression in human glioblastoma cells

Cancer gene therapy, 2018-12, Vol.25 (11-12), p.309-316

2018

Volltextzugriff (PDF)

Integrated Transcriptomic Analysis Reveals the Molecular Mechanism of Meningiomas by Weighted Gene Coexpression Network Analysis

BioMed research international, 2020, Vol.2020 (2020), p.1-12

2020

Volltextzugriff (PDF)

Integrated Transcriptome Analyses and Experimental Verifications of Mesenchymal-Associated TNFRSF1A as a Diagnostic and Prognostic Biomarker in Gliomas

Frontiers in oncology, 2020-03, Vol.10, p.250-250

2020

Volltextzugriff (PDF)

Examining the biomarkers and molecular mechanisms of medulloblastoma based on bioinformatics analysis

Oncology letters, 2019-07, Vol.18 (1), p.433-441

2019

Volltextzugriff (PDF)

Identification of biomarkers and construction of a microRNA‑mRNA regulatory network for ependymoma using integrated bioinformatics analysis

Oncology letters, 2019-12, Vol.18 (6), p.6079-6089

2019

Volltextzugriff (PDF)

Hydroxyapatite nanoparticles inhibit the growth of human glioma cells in vitro and in vivo

International journal of nanomedicine, 2012-01, Vol.7 (default), p.3659-3666

2012

Volltextzugriff (PDF)

Upregulation of SATB1 is associated with the development and progression of glioma

Journal of translational medicine, 2012-07, Vol.10 (1), p.149-149, Article 149

2012

Volltextzugriff (PDF)

Promoter methylation and downregulation of SLC22A18 are associated with the development and progression of human glioma

Journal of translational medicine, 2011-09, Vol.9 (1), p.156-156, Article 156

2011

Volltextzugriff (PDF)

Predictive value of the SLC22A18 protein expression in glioblastoma patients receiving temozolomide therapy

Journal of translational medicine, 2013-03, Vol.11 (1), p.69-69, Article 69

2013

Volltextzugriff (PDF)

c-Met-targeted RNA interference inhibits growth and metastasis of glioma U251 cells in vitro

Journal of neuro-oncology, 2009-06, Vol.93 (2), p.183-189

2009

Volltextzugriff (PDF)

Stabilization of hepatocyte growth factor mRNA by hypoxia-inducible factor 1

Molecular biology reports, 2009-09, Vol.36 (7), p.1967-1975

2009

Volltextzugriff (PDF)

In vitro and in vivo radiosensitization induced by hydroxyapatite nanoparticles

Neuro-oncology (Charlottesville, Va.), 2013-07, Vol.15 (7), p.880-890

2013

Volltextzugriff (PDF)

c-Met Antisense Oligodeoxynucleotides as a Novel Therapeutic Agent for Glioma: In Vitro and In Vivo Studies of Uptake, Effects, and Toxicity

The Journal of surgical research, 2007-08, Vol.141 (2), p.284-288

2007

Volltextzugriff (PDF)

Correlation of low SLC22A18 expression with poor prognosis in patients with glioma

Journal of clinical neuroscience, 2012-01, Vol.19 (1), p.95-98

2012

Volltextzugriff (PDF)

Inhibition of human glioma U251 cells growth in vitro and in vivo by hydroxyapatite nanoparticle-assisted delivery of short hairpin RNAs against SATB1

Molecular biology reports, 2014-02, Vol.41 (2), p.977-986

2014

Volltextzugriff (PDF)

Induction of proline-rich tyrosine kinase 2 activation-mediated C6 glioma cell invasion after anti-vascular endothelial growth factor therapy

Journal of translational medicine, 2014-05, Vol.12 (1), p.148-148, Article 148

2014

Volltextzugriff (PDF)

Relationship between SATB1 expression and prognosis in astrocytoma

Journal of clinical neuroscience, 2013-04, Vol.20 (4), p.543-547

2013

Volltextzugriff (PDF)

Correlation between SATB1 and Bcl-2 expression in human glioblastoma multiforme

Molecular medicine reports, 2013-01, Vol.7 (1), p.139-143

2013

Volltextzugriff (PDF)

Giant intradiploic epidermoid cyst of the occipital bone

Journal of clinical neuroscience, 2009-11, Vol.16 (11), p.1478-1480

2009

Volltextzugriff (PDF)

Expression of HGF and VEGF in the cerebral tissue of adult rats with chronic hydrocephalus after subarachnoid hemorrhage

Molecular medicine reports, 2011-09, Vol.4 (5), p.785-791

2011

Volltextzugriff (PDF)

Effect of 5-Aza-2'-deoxycytidine on SLC22A18 in glioma U251 cells

Molecular medicine reports, 2012-01, Vol.5 (1), p.138-141

2012

Volltextzugriff (PDF)

c-Met antisense oligodeoxynucleotides increase sensitivity of human glioma cells to paclitaxel

Oncology reports, 2010-07, Vol.24 (1), p.189-194

2010

Volltextzugriff (PDF)

In vitro and in vivo potentiating the cytotoxic effect of radiation on human U251 gliomas by the c-Met antisense oligodeoxynucleotides

Journal of neuro-oncology, 2006-11, Vol.80 (2), p.143-149

2006

Volltextzugriff (PDF)

Elevated expression of solute carrier family 22 member 18 increases the sensitivity of U251 glioma cells to BCNU

Oncology letters, 2011-11, Vol.2 (6), p.1139-1142

2011

Volltextzugriff (PDF)

1 – 25 von 119

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(96)
Mit Volltextzugriff
(105)

Publikationsform

Artikel
(115)
Tagungsberichte
(4)

Sprache

Englisch
(106)
Chinesisch
(16)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

GNG5 is an unfavourable independent prognostic indicator of gliomas

Silencing SATB1 overcomes temozolomide resistance by downregulating MGMT expression and upregulating SLC22A18 expression in human glioblastoma cells

Integrated Transcriptomic Analysis Reveals the Molecular Mechanism of Meningiomas by Weighted Gene Coexpression Network Analysis

Integrated Transcriptome Analyses and Experimental Verifications of Mesenchymal-Associated TNFRSF1A as a Diagnostic and Prognostic Biomarker in Gliomas

Examining the biomarkers and molecular mechanisms of medulloblastoma based on bioinformatics analysis

Identification of biomarkers and construction of a microRNA‑mRNA regulatory network for ependymoma using integrated bioinformatics analysis

Hydroxyapatite nanoparticles inhibit the growth of human glioma cells in vitro and in vivo

Upregulation of SATB1 is associated with the development and progression of glioma

Promoter methylation and downregulation of SLC22A18 are associated with the development and progression of human glioma

Predictive value of the SLC22A18 protein expression in glioblastoma patients receiving temozolomide therapy

c-Met-targeted RNA interference inhibits growth and metastasis of glioma U251 cells in vitro

Stabilization of hepatocyte growth factor mRNA by hypoxia-inducible factor 1

In vitro and in vivo radiosensitization induced by hydroxyapatite nanoparticles

c-Met Antisense Oligodeoxynucleotides as a Novel Therapeutic Agent for Glioma: In Vitro and In Vivo Studies of Uptake, Effects, and Toxicity

Correlation of low SLC22A18 expression with poor prognosis in patients with glioma

Inhibition of human glioma U251 cells growth in vitro and in vivo by hydroxyapatite nanoparticle-assisted delivery of short hairpin RNAs against SATB1

Induction of proline-rich tyrosine kinase 2 activation-mediated C6 glioma cell invasion after anti-vascular endothelial growth factor therapy

Relationship between SATB1 expression and prognosis in astrocytoma

Correlation between SATB1 and Bcl-2 expression in human glioblastoma multiforme

Giant intradiploic epidermoid cyst of the occipital bone

Expression of HGF and VEGF in the cerebral tissue of adult rats with chronic hydrocephalus after subarachnoid hemorrhage

Effect of 5-Aza-2'-deoxycytidine on SLC22A18 in glioma U251 cells

c-Met antisense oligodeoxynucleotides increase sensitivity of human glioma cells to paclitaxel

In vitro and in vivo potentiating the cytotoxic effect of radiation on human U251 gliomas by the c-Met antisense oligodeoxynucleotides

Elevated expression of solute carrier family 22 member 18 increases the sensitivity of U251 glioma cells to BCNU

Suchergebnisse filtern